Related Experiment Video
Updated: Jul 14, 2026

A Hydrophobic Tissue Clearing Method for Rat Brain Tissue
Published on: December 23, 2020
Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins
Jeffrey A Rumbaugh1, Guanhan Li, Jeffrey Rothstein
1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. jrumbaug@jhmi.edu
Human immunodeficiency virus (HIV) proteins Tat and gp120 have been implicated in the pathogenesis of HIV dementia by various mechanisms, including down-regulation of excitatory amino acid transporter-2 (EAAT2), which is responsible for inactivation of synaptic glutamate. Recent work indicates that beta-lactam antibiotics are potent stimulators of EAAT2 expression. The authors treated mixed human fetal neuronal cultures with recombinant gp120 or Tat, in the presence or absence of ceftriaxone, and determined neurotoxicity by measuring mitochondrial membrane potential and neuronal cell death. Ceftriaxone produced dose-dependent attenuation of the neurotoxicity and neuronal cell death caused by both viral proteins. This study demonstrates that this class of drugs may have therapeutic efficacy in HIV dementia.
Human immunodeficiency virus (HIV) proteins Tat and gp120 have been implicated in the pathogenesis of HIV dementia by various mechanisms, including down-regulation of excitatory amino acid transporter-2 (EAAT2), which is responsible for inactivation of synaptic glutamate. Recent work indicates that beta-lactam antibiotics are potent stimulators of EAAT2 expression. The authors treated mixed human fetal neuronal cultures with recombinant gp120 or Tat, in the presence or absence of ceftriaxone, and determined neurotoxicity by measuring mitochondrial membrane potential and neuronal cell death. Ceftriaxone produced dose-dependent attenuation of the neurotoxicity and neuronal cell death caused by both viral proteins. This study demonstrates that this class of drugs may have therapeutic efficacy in HIV dementia.
Related Concept Videos
Cryptococcal Meningitis
Inhibitors of Virion Maturation and Assembly
Diphtheria
Inhibitors of Viral Protein Synthesis
Retrovirus Life Cycles
Encephalitis ll: Pathophysiology

